Abstract

Exosomes are small vesicles which are produced by the cells and released into the surrounding space. They can transfer biomolecules into recipient cells. The main goal of the work was to study the exosome involvement in the cell transfer of hormonal resistance. The experiments were performed on in vitro cultured estrogen-dependent MCF-7 breast cancer cells and MCF-7 sublines resistant to SERM tamoxifen and/or biguanide metformin, which exerts its anti-proliferative effect, at least in a part, via the suppression of estrogen machinery. The exosomes were purified by differential ultracentrifugation, cell response to tamoxifen was determined by MTT test, and the level and activity of signaling proteins were determined by Western blot and reporter analysis. We found that the treatment of the parent MCF-7 cells with exosomes from the resistant cells within 14 days lead to the partial resistance of the MCF-7 cells to antiestrogen drugs. The primary resistant cells and the cells with the exosome-induced resistance were characterized with these common features: decrease in ERα activity and parallel activation of Akt and AP-1, NF-κB, and SNAIL1 transcriptional factors. In general, we evaluate the established results as the evidence of the possible exosome involvement in the transferring of the hormone/metformin resistance in breast cancer cells.

Highlights

  • The efficiency of endocrine therapy of tumors, including breast cancer, is limited by the development of hormone-independent tumors which are resistant to antiestrogens initially or acquire resistance under prolonged therapy with antiestrogens [1,2,3]

  • To further explore the relations between acquired resistance to metformin and tamoxifen, we compared the sensitivity of two independent MCF-7 sublines: MCF-7/T subline developed by long-term tamoxifen treatment and MCF-7/M subline generated under metformin treatment, to these drugs

  • The work was based on the hypothesis that the co-cultivation of the hormone-resistant and sensitive cells may lead to horizontal transfer of the hormonal resistance to the sensitive cells—as a result of the secretion of the specific factors, acting in the paracrine manner or via the direct cell-cell contacts

Read more

Summary

Introduction

The efficiency of endocrine therapy of tumors, including breast cancer, is limited by the development of hormone-independent tumors which are resistant to antiestrogens initially or acquire resistance under prolonged therapy with antiestrogens (tamoxifen, raloxifene) [1,2,3]. The mechanism of hormonal resistance was investigated thoroughly. The main ways of the progression of hormonal resistance were found to include the loss or dysregulation of estrogen receptors, stimulation of growth-dependent pathways and activation of epithelial-mesenhymal transition, etc. The role of the intercellular interactions in the progression of hormonal resistance is less researched. A few studies demonstrate the effect of the horizontal transfer of the resistance between the cells, mainly of the development of multidrug resistance. The effect of the cell-to-cell transfer of Molecules 2018, 23, 829; doi:10.3390/molecules2304829 www.mdpi.com/journal/molecules

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call